Strand Therapeutics Inc.
Boston, MA
- UEI
- PJ23TRKRFVB5
- CAGE
- 8BLB2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 20 Overland St a, Boston, MA 02215, USA
- Website
- strandtx.com
- Founded
- 2017
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,249,609 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sentinox (STX)-005: a next-generation therapy for autoimmune disease to sustain force readiness | Air Force Research Laboratory (AFMC) | $1,249,609 |
Quick answers
Is Strand Therapeutics Inc. registered in SAM.gov?
Strand Therapeutics Inc.'s SAM.gov registration expired on September 11, 2026.
How much has Strand Therapeutics Inc. received in federal contracts?
Federal contracts obligated $1,249,609 to Strand Therapeutics Inc. in fiscal year 2025.
What is Strand Therapeutics Inc.'s most recent federal award?
Strand Therapeutics Inc.'s most recent federal contract award is Sentinox (STX)-005: a next-generation therapy for autoimmune disease to sustain force readiness (FA864925P0501), from Air Force Research Laboratory (AFMC), on August 29, 2025.
On GovTribe
See Strand Therapeutics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors